Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smad1
|
ENSMUSG00000031681.8 | SMAD family member 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_79350015_79350565 | Smad1 | 239 | 0.927654 | 0.56 | 7.4e-06 | Click! |
chr8_79372746_79372903 | Smad1 | 16146 | 0.172066 | -0.56 | 9.6e-06 | Click! |
chr8_79352002_79352153 | Smad1 | 2026 | 0.318969 | 0.55 | 1.6e-05 | Click! |
chr8_79355696_79356363 | Smad1 | 649 | 0.714944 | 0.46 | 3.8e-04 | Click! |
chr8_79346624_79346783 | Smad1 | 3348 | 0.236413 | -0.44 | 6.9e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_124439906_124440949 | 27.87 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr18_12720218_12720585 | 24.44 |
Mir1948 |
microRNA 1948 |
5590 |
0.15 |
chr3_82406341_82406796 | 19.01 |
Map9 |
microtubule-associated protein 9 |
26495 |
0.24 |
chr17_13590938_13591623 | 18.76 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
22416 |
0.14 |
chr12_3236518_3237725 | 18.41 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr9_50832696_50833456 | 16.90 |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
2495 |
0.22 |
chr17_13654565_13655321 | 16.47 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr18_81251894_81252538 | 14.62 |
Gm30192 |
predicted gene, 30192 |
12475 |
0.22 |
chr19_41746384_41746957 | 14.20 |
Slit1 |
slit guidance ligand 1 |
3005 |
0.27 |
chr4_110050502_110051534 | 13.86 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr10_41934443_41935500 | 13.68 |
Sesn1 |
sestrin 1 |
36598 |
0.15 |
chr6_124915577_124916697 | 13.42 |
Ptms |
parathymosin |
608 |
0.37 |
chr12_111758304_111760062 | 13.37 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr10_81364518_81366962 | 13.10 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr7_45460493_45461322 | 12.61 |
Ftl1 |
ferritin light polypeptide 1 |
1023 |
0.19 |
chr8_12486572_12486996 | 12.54 |
4933439N14Rik |
RIKEN cDNA 4933439N14 gene |
16115 |
0.15 |
chrX_75673394_75674325 | 12.39 |
Gm15065 |
predicted gene 15065 |
31550 |
0.13 |
chr1_155233440_155234889 | 12.35 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr13_49370675_49371884 | 11.96 |
Bicd2 |
BICD cargo adaptor 2 |
11810 |
0.19 |
chr2_164131495_164131907 | 11.94 |
Gm11455 |
predicted gene 11455 |
4002 |
0.13 |
chr3_108409761_108410771 | 11.87 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
5286 |
0.1 |
chr9_41375999_41376652 | 11.74 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
4 |
0.98 |
chr10_81559146_81561402 | 11.68 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr14_14350947_14351733 | 11.68 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr5_118156978_118157626 | 11.43 |
Fbxw8 |
F-box and WD-40 domain protein 8 |
1838 |
0.27 |
chr2_127521161_127522051 | 11.38 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr8_24626724_24627273 | 11.15 |
Adam18 |
a disintegrin and metallopeptidase domain 18 |
1256 |
0.43 |
chr8_12873206_12874084 | 11.02 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr16_46009777_46011157 | 10.96 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
249 |
0.91 |
chr12_44329338_44330111 | 10.89 |
Nrcam |
neuronal cell adhesion molecule |
474 |
0.8 |
chr8_12947304_12948554 | 10.77 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chr4_107680369_107681106 | 10.62 |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
223 |
0.9 |
chr8_4212633_4214018 | 10.23 |
Prr36 |
proline rich 36 |
3587 |
0.11 |
chr3_86786918_86787697 | 10.16 |
Dclk2 |
doublecortin-like kinase 2 |
5008 |
0.21 |
chr1_119033632_119034415 | 10.15 |
Gli2 |
GLI-Kruppel family member GLI2 |
19316 |
0.19 |
chr5_100108777_100109262 | 10.14 |
Tmem150c |
transmembrane protein 150C |
13777 |
0.15 |
chr11_6603325_6604219 | 10.13 |
Nacad |
NAC alpha domain containing |
2281 |
0.14 |
chr7_99267195_99268129 | 10.09 |
Map6 |
microtubule-associated protein 6 |
173 |
0.76 |
chr1_85916954_85917154 | 10.08 |
Itm2c |
integral membrane protein 2C |
10893 |
0.12 |
chr17_7700126_7700299 | 9.97 |
Gm25872 |
predicted gene, 25872 |
4628 |
0.26 |
chr17_83889634_83890169 | 9.96 |
1810073O08Rik |
RIKEN cDNA 1810073O08 gene |
28036 |
0.12 |
chr16_18628137_18628905 | 9.92 |
Septin5 |
septin 5 |
1183 |
0.32 |
chr11_32161571_32162227 | 9.92 |
Gm12109 |
predicted gene 12109 |
23106 |
0.12 |
chr16_33605736_33606716 | 9.89 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr8_4192812_4193553 | 9.87 |
Evi5l |
ecotropic viral integration site 5 like |
1890 |
0.19 |
chr17_5082966_5083455 | 9.86 |
Gm15599 |
predicted gene 15599 |
28900 |
0.2 |
chr12_29871996_29872873 | 9.72 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr14_13284898_13285304 | 9.59 |
Synpr |
synaptoporin |
260 |
0.69 |
chr17_56693837_56694281 | 9.48 |
Ranbp3 |
RAN binding protein 3 |
2676 |
0.16 |
chr14_39317462_39317779 | 9.47 |
Gm20642 |
predicted gene 20642 |
97549 |
0.09 |
chr13_41339875_41340134 | 9.45 |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated gene 9 |
19243 |
0.13 |
chr8_110716047_110716632 | 9.38 |
Mtss2 |
MTSS I-BAR domain containing 2 |
5137 |
0.18 |
chr6_90495493_90495923 | 9.32 |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
9281 |
0.11 |
chr13_15759168_15760299 | 9.18 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr8_95703143_95704225 | 9.16 |
Ndrg4 |
N-myc downstream regulated gene 4 |
614 |
0.57 |
chr12_25871193_25871842 | 9.09 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chr11_43548063_43548966 | 9.09 |
Ccnjl |
cyclin J-like |
19268 |
0.13 |
chr7_44443191_44443771 | 9.04 |
Lrrc4b |
leucine rich repeat containing 4B |
744 |
0.4 |
chr8_4206127_4207837 | 9.02 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr7_98177614_98179153 | 8.99 |
Capn5 |
calpain 5 |
109 |
0.93 |
chr10_78464271_78465733 | 8.88 |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
27 |
0.93 |
chr10_80301145_80301602 | 8.77 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
338 |
0.69 |
chr15_27914232_27914818 | 8.75 |
Trio |
triple functional domain (PTPRF interacting) |
4746 |
0.25 |
chr9_26519987_26520600 | 8.74 |
Gm30313 |
predicted gene, 30313 |
29660 |
0.23 |
chr16_91962945_91963627 | 8.72 |
Gm27773 |
predicted gene, 27773 |
19138 |
0.1 |
chr1_82292424_82293208 | 8.70 |
Irs1 |
insulin receptor substrate 1 |
1400 |
0.42 |
chr17_7700834_7701025 | 8.68 |
Gm25872 |
predicted gene, 25872 |
3911 |
0.27 |
chr3_108085301_108086522 | 8.67 |
Gm12500 |
predicted gene 12500 |
65 |
0.8 |
chr3_85300229_85300586 | 8.65 |
1700036G14Rik |
RIKEN cDNA 1700036G14 gene |
17112 |
0.24 |
chr15_40114597_40115428 | 8.64 |
9330182O14Rik |
RIKEN cDNA 9330182O14 gene |
19353 |
0.17 |
chr19_38054215_38055320 | 8.62 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr9_86879639_86880662 | 8.60 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chr10_118102987_118104071 | 8.47 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
8988 |
0.17 |
chr12_29527021_29527799 | 8.46 |
Myt1l |
myelin transcription factor 1-like |
974 |
0.61 |
chr2_94246412_94247550 | 8.44 |
Mir670hg |
MIR670 host gene (non-protein coding) |
3643 |
0.17 |
chr5_112213704_112214228 | 8.44 |
Gm26953 |
predicted gene, 26953 |
1495 |
0.29 |
chr15_36943512_36944089 | 8.40 |
Gm34590 |
predicted gene, 34590 |
4936 |
0.18 |
chr14_123626303_123627238 | 8.36 |
Nalcn |
sodium leak channel, non-selective |
106 |
0.98 |
chr14_24617341_24617911 | 8.34 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
58 |
0.64 |
chr9_103524107_103524264 | 8.32 |
Gm32743 |
predicted gene, 32743 |
2398 |
0.17 |
chr6_82939285_82939948 | 8.28 |
Sema4f |
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain |
71 |
0.94 |
chr19_33391464_33392505 | 8.24 |
Rnls |
renalase, FAD-dependent amine oxidase |
281 |
0.91 |
chr3_73056881_73057482 | 8.24 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
238 |
0.92 |
chr10_75704011_75704915 | 8.22 |
Cabin1 |
calcineurin binding protein 1 |
4088 |
0.16 |
chr9_108587464_108588439 | 8.21 |
Gm49209 |
predicted gene, 49209 |
899 |
0.26 |
chr17_48776504_48776949 | 8.21 |
Gm45330 |
predicted gene 45330 |
37980 |
0.2 |
chr7_34570196_34571084 | 8.18 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr9_45380501_45380923 | 8.17 |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
10270 |
0.12 |
chr9_41697271_41698297 | 8.14 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr9_62536098_62537614 | 8.10 |
Coro2b |
coronin, actin binding protein, 2B |
104 |
0.97 |
chr12_85350911_85351187 | 8.09 |
Tmed10 |
transmembrane p24 trafficking protein 10 |
129 |
0.93 |
chr12_12904167_12904754 | 8.07 |
4930519A11Rik |
RIKEN cDNA 4930519A11 gene |
90 |
0.95 |
chr7_18926314_18927174 | 8.06 |
Nova2 |
NOVA alternative splicing regulator 2 |
856 |
0.42 |
chr4_114818962_114819553 | 8.06 |
Gm12830 |
predicted gene 12830 |
2465 |
0.28 |
chr12_29279690_29280795 | 8.05 |
Gm6989 |
predicted gene 6989 |
37326 |
0.21 |
chr2_146330592_146331553 | 8.03 |
Gm14117 |
predicted gene 14117 |
25525 |
0.19 |
chr8_65617940_65618821 | 8.02 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr10_81429712_81431957 | 8.02 |
Nfic |
nuclear factor I/C |
171 |
0.85 |
chr8_87702762_87703444 | 8.00 |
Zfp423 |
zinc finger protein 423 |
100720 |
0.07 |
chr3_38299580_38299934 | 7.99 |
Gm42920 |
predicted gene 42920 |
69641 |
0.09 |
chr1_132880253_132881745 | 7.99 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
644 |
0.72 |
chr2_32625098_32626151 | 7.97 |
Ak1 |
adenylate kinase 1 |
186 |
0.86 |
chr14_60554058_60554987 | 7.89 |
Gm47810 |
predicted gene, 47810 |
42380 |
0.15 |
chr14_34822716_34823193 | 7.88 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
2846 |
0.27 |
chrX_102003725_102004324 | 7.80 |
Nhsl2 |
NHS-like 2 |
1020 |
0.5 |
chr4_32889306_32889537 | 7.80 |
Gm11941 |
predicted gene 11941 |
3265 |
0.23 |
chr6_55451539_55452374 | 7.78 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
22 |
0.98 |
chr2_26594675_26595827 | 7.76 |
Egfl7 |
EGF-like domain 7 |
3104 |
0.11 |
chr14_19808924_19809109 | 7.75 |
Nid2 |
nidogen 2 |
3780 |
0.19 |
chr9_25377882_25378402 | 7.74 |
Gm18891 |
predicted gene, 18891 |
28644 |
0.17 |
chr1_176993767_176994494 | 7.70 |
Sdccag8 |
serologically defined colon cancer antigen 8 |
3879 |
0.18 |
chr15_66239660_66240017 | 7.67 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr13_84565989_84566203 | 7.65 |
Gm26913 |
predicted gene, 26913 |
124845 |
0.06 |
chr5_137738513_137738869 | 7.64 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
1027 |
0.32 |
chr17_27679167_27679824 | 7.61 |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
5686 |
0.12 |
chr10_39133560_39134579 | 7.59 |
Tube1 |
tubulin, epsilon 1 |
1 |
0.66 |
chr11_3132475_3133419 | 7.58 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
3060 |
0.17 |
chr4_118261785_118262467 | 7.57 |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
25681 |
0.15 |
chr1_59535160_59535834 | 7.56 |
1700122D07Rik |
RIKEN cDNA 1700122D07 gene |
1732 |
0.27 |
chr15_30693718_30694224 | 7.54 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
10812 |
0.25 |
chr10_5922231_5922649 | 7.51 |
Rgs17 |
regulator of G-protein signaling 17 |
40 |
0.99 |
chr9_21196197_21196830 | 7.50 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
192 |
0.89 |
chr14_25586973_25588068 | 7.49 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
19837 |
0.17 |
chr17_56472537_56473329 | 7.49 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr9_43699339_43700154 | 7.49 |
Gm5364 |
predicted gene 5364 |
16693 |
0.14 |
chr3_107536889_107537478 | 7.49 |
Ubl4b |
ubiquitin-like 4B |
17890 |
0.15 |
chr3_88231481_88231652 | 7.48 |
Gm3764 |
predicted gene 3764 |
2783 |
0.11 |
chr10_43023446_43023814 | 7.48 |
Gm47815 |
predicted gene, 47815 |
11363 |
0.22 |
chr15_67898912_67899432 | 7.47 |
Gm49408 |
predicted gene, 49408 |
25344 |
0.23 |
chr10_81464661_81465630 | 7.46 |
Gm16105 |
predicted gene 16105 |
3986 |
0.08 |
chr8_41054736_41055125 | 7.44 |
Mtus1 |
mitochondrial tumor suppressor 1 |
136 |
0.94 |
chr2_173257495_173258460 | 7.43 |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
18212 |
0.17 |
chr2_26932798_26934207 | 7.42 |
Surf4 |
surfeit gene 4 |
119 |
0.82 |
chr18_83400101_83400345 | 7.41 |
Gm50413 |
predicted gene, 50413 |
602 |
0.68 |
chr2_146787470_146787824 | 7.40 |
Gm14111 |
predicted gene 14111 |
31942 |
0.18 |
chr2_153045880_153046226 | 7.37 |
Xkr7 |
X-linked Kx blood group related 7 |
14201 |
0.12 |
chr15_27997341_27997770 | 7.34 |
Trio |
triple functional domain (PTPRF interacting) |
2192 |
0.36 |
chr4_118366779_118367198 | 7.33 |
Szt2 |
SZT2 subunit of KICSTOR complex |
1922 |
0.25 |
chr6_114289060_114289436 | 7.32 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
6458 |
0.27 |
chr7_31148783_31149449 | 7.31 |
G630030J09Rik |
RIKEN cDNA G630030J09 gene |
412 |
0.68 |
chr9_37076724_37076963 | 7.30 |
Pknox2 |
Pbx/knotted 1 homeobox 2 |
6436 |
0.17 |
chr4_100973634_100974412 | 7.23 |
Cachd1 |
cache domain containing 1 |
20588 |
0.19 |
chr12_29663403_29663734 | 7.22 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
22877 |
0.25 |
chr14_25401486_25402359 | 7.21 |
Gm26660 |
predicted gene, 26660 |
22313 |
0.15 |
chr14_75473590_75473918 | 7.20 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
17772 |
0.22 |
chr5_112577448_112578314 | 7.18 |
Sez6l |
seizure related 6 homolog like |
696 |
0.62 |
chr13_59092007_59092498 | 7.17 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
8159 |
0.17 |
chr18_4785343_4785631 | 7.15 |
Gm10556 |
predicted gene 10556 |
26999 |
0.2 |
chr10_39672573_39673015 | 7.15 |
Gm8899 |
predicted gene 8899 |
10705 |
0.13 |
chr12_28700549_28700979 | 7.14 |
Trappc12 |
trafficking protein particle complex 12 |
845 |
0.53 |
chr5_30920760_30922186 | 7.13 |
Khk |
ketohexokinase |
42 |
0.93 |
chr11_46234019_46234277 | 7.13 |
Fndc9 |
fibronectin type III domain containing 9 |
1383 |
0.35 |
chr3_94478560_94479074 | 7.12 |
Celf3 |
CUGBP, Elav-like family member 3 |
14 |
0.94 |
chr6_81660570_81661025 | 7.11 |
Gm26264 |
predicted gene, 26264 |
22486 |
0.22 |
chr7_111896291_111896806 | 7.10 |
Gm45588 |
predicted gene 45588 |
37993 |
0.17 |
chr18_4504292_4504526 | 7.09 |
Gm7411 |
predicted gene 7411 |
19940 |
0.2 |
chr9_45663652_45664379 | 7.09 |
Dscaml1 |
DS cell adhesion molecule like 1 |
8822 |
0.19 |
chr10_79681206_79682337 | 7.07 |
Cdc34 |
cell division cycle 34 |
424 |
0.63 |
chr9_37229794_37230412 | 7.07 |
Slc37a2 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 2 |
5051 |
0.11 |
chr2_31263681_31264149 | 7.05 |
Ncs1 |
neuronal calcium sensor 1 |
17749 |
0.16 |
chr3_146769028_146769237 | 7.03 |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
1129 |
0.48 |
chr5_33995599_33996957 | 7.03 |
Nat8l |
N-acetyltransferase 8-like |
294 |
0.82 |
chr7_60003898_60004931 | 7.02 |
Snurf |
SNRPN upstream reading frame |
635 |
0.26 |
chr14_24578890_24579079 | 7.02 |
4930542C16Rik |
RIKEN cDNA 4930542C16 gene |
38320 |
0.14 |
chr7_44441934_44442325 | 7.02 |
Lrrc4b |
leucine rich repeat containing 4B |
356 |
0.7 |
chr9_27307063_27307732 | 7.02 |
Igsf9b |
immunoglobulin superfamily, member 9B |
8169 |
0.2 |
chr9_16399054_16399273 | 6.99 |
Fat3 |
FAT atypical cadherin 3 |
20932 |
0.24 |
chr15_83771740_83771941 | 6.99 |
Mpped1 |
metallophosphoesterase domain containing 1 |
7627 |
0.23 |
chr3_88207026_88207397 | 6.99 |
Gm3764 |
predicted gene 3764 |
101 |
0.91 |
chr9_56738591_56739084 | 6.98 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
30286 |
0.16 |
chr7_129664007_129664606 | 6.98 |
Gm33248 |
predicted gene, 33248 |
3099 |
0.26 |
chr5_24423517_24424454 | 6.97 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
126 |
0.78 |
chr4_82532833_82533165 | 6.93 |
Gm11266 |
predicted gene 11266 |
24983 |
0.17 |
chr6_25686769_25687229 | 6.91 |
Gpr37 |
G protein-coupled receptor 37 |
2793 |
0.38 |
chr13_59091457_59091627 | 6.87 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
7449 |
0.18 |
chr5_37241363_37242150 | 6.86 |
Crmp1 |
collapsin response mediator protein 1 |
184 |
0.95 |
chr1_157439951_157440671 | 6.86 |
Cryzl2 |
crystallin zeta like 2 |
18266 |
0.12 |
chr7_44336781_44337350 | 6.84 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1049 |
0.26 |
chr4_23982818_23983489 | 6.83 |
Gm28448 |
predicted gene 28448 |
49199 |
0.19 |
chr4_111597201_111597750 | 6.81 |
Agbl4 |
ATP/GTP binding protein-like 4 |
30750 |
0.22 |
chr12_33341296_33341797 | 6.81 |
Atxn7l1 |
ataxin 7-like 1 |
3759 |
0.23 |
chr4_32923442_32923826 | 6.81 |
Ankrd6 |
ankyrin repeat domain 6 |
129 |
0.96 |
chr10_70686519_70686892 | 6.80 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
30740 |
0.17 |
chr8_33992574_33993302 | 6.80 |
Gm45817 |
predicted gene 45817 |
5738 |
0.17 |
chr9_23581417_23581624 | 6.80 |
Gm3011 |
predicted gene 3011 |
194972 |
0.03 |
chr11_96876294_96876734 | 6.80 |
Gm11523 |
predicted gene 11523 |
2560 |
0.14 |
chr10_23674681_23675112 | 6.79 |
4930520K02Rik |
RIKEN cDNA 4930520K02 gene |
52748 |
0.11 |
chr5_124043534_124044007 | 6.79 |
Gm43661 |
predicted gene 43661 |
8582 |
0.1 |
chr13_109116814_109117670 | 6.79 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
601 |
0.86 |
chr2_124792603_124792967 | 6.78 |
Gm13994 |
predicted gene 13994 |
84130 |
0.1 |
chr7_63965140_63965547 | 6.78 |
Gm45052 |
predicted gene 45052 |
3103 |
0.18 |
chr2_94178364_94179081 | 6.76 |
Mir670hg |
MIR670 host gene (non-protein coding) |
193 |
0.93 |
chr10_118121607_118122166 | 6.76 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
9369 |
0.16 |
chr6_39242951_39243777 | 6.74 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr14_55053693_55054126 | 6.74 |
Zfhx2os |
zinc finger homeobox 2, opposite strand |
38 |
0.92 |
chr8_84793716_84794468 | 6.74 |
Nfix |
nuclear factor I/X |
5932 |
0.1 |
chr3_8510910_8511440 | 6.72 |
Stmn2 |
stathmin-like 2 |
1589 |
0.43 |
chr4_102239723_102239916 | 6.72 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
14923 |
0.28 |
chr12_51001833_51002010 | 6.71 |
Gm40421 |
predicted gene, 40421 |
2952 |
0.27 |
chr5_35907951_35908424 | 6.71 |
Afap1 |
actin filament associated protein 1 |
4895 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.6 | 37.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
9.3 | 28.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
8.7 | 34.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
6.7 | 33.7 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
6.1 | 18.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
6.0 | 18.0 | GO:0021564 | vagus nerve development(GO:0021564) |
5.9 | 17.8 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
5.2 | 15.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
5.1 | 15.4 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
5.0 | 19.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
5.0 | 5.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
4.9 | 4.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
4.7 | 14.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
4.7 | 4.7 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
4.7 | 23.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
4.4 | 8.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
4.3 | 38.6 | GO:0071625 | vocalization behavior(GO:0071625) |
4.3 | 34.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
4.2 | 33.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
4.2 | 4.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
4.1 | 8.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
4.1 | 8.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
4.0 | 12.0 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
4.0 | 15.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
4.0 | 11.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
3.9 | 31.4 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
3.8 | 11.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
3.8 | 7.5 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
3.7 | 14.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
3.7 | 7.4 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
3.7 | 29.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.6 | 10.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
3.6 | 10.9 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.6 | 43.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
3.6 | 18.0 | GO:0022038 | corpus callosum development(GO:0022038) |
3.6 | 14.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
3.6 | 3.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
3.5 | 17.7 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
3.5 | 17.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
3.5 | 17.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
3.3 | 3.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
3.2 | 9.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
3.2 | 9.6 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
3.2 | 9.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
3.2 | 9.5 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
3.1 | 9.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
3.1 | 6.3 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
3.1 | 18.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.1 | 6.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
3.0 | 24.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
3.0 | 9.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
3.0 | 9.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
3.0 | 9.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
3.0 | 6.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
3.0 | 3.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
3.0 | 8.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.0 | 38.4 | GO:0008038 | neuron recognition(GO:0008038) |
2.9 | 2.9 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
2.9 | 14.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
2.9 | 8.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.8 | 8.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.8 | 8.5 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
2.8 | 8.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.8 | 8.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
2.7 | 5.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.7 | 8.2 | GO:0001927 | exocyst assembly(GO:0001927) |
2.7 | 10.9 | GO:0030091 | protein repair(GO:0030091) |
2.7 | 10.8 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.7 | 10.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.7 | 8.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.7 | 5.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.7 | 5.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
2.7 | 8.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.6 | 5.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.6 | 7.8 | GO:0061743 | motor learning(GO:0061743) |
2.6 | 5.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.6 | 7.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
2.6 | 12.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
2.5 | 15.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.5 | 12.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.5 | 50.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.5 | 5.1 | GO:0060166 | olfactory pit development(GO:0060166) |
2.5 | 17.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
2.5 | 15.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
2.5 | 12.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
2.5 | 9.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
2.5 | 4.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
2.4 | 7.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
2.4 | 7.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
2.4 | 4.8 | GO:0046959 | habituation(GO:0046959) |
2.4 | 4.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
2.4 | 12.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
2.4 | 12.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
2.4 | 12.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
2.4 | 35.9 | GO:0001964 | startle response(GO:0001964) |
2.4 | 119.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.4 | 4.7 | GO:0030035 | microspike assembly(GO:0030035) |
2.4 | 11.8 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
2.4 | 7.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.4 | 7.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.3 | 9.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.3 | 35.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
2.3 | 2.3 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.3 | 4.6 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
2.3 | 11.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.3 | 11.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.3 | 9.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.2 | 6.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
2.2 | 17.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
2.2 | 2.2 | GO:0033058 | directional locomotion(GO:0033058) |
2.2 | 28.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
2.2 | 8.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
2.1 | 10.6 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
2.1 | 14.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
2.1 | 25.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.1 | 10.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.1 | 2.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
2.1 | 4.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
2.1 | 8.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.0 | 32.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
2.0 | 4.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
2.0 | 58.5 | GO:0019228 | neuronal action potential(GO:0019228) |
2.0 | 6.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
2.0 | 20.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
2.0 | 14.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
2.0 | 2.0 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
2.0 | 2.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
2.0 | 9.9 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
2.0 | 11.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.0 | 3.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.9 | 5.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.9 | 11.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.9 | 7.7 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.9 | 11.5 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.9 | 5.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.9 | 5.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.9 | 5.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.9 | 5.6 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.9 | 9.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.9 | 3.7 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.9 | 5.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.9 | 3.7 | GO:0007412 | axon target recognition(GO:0007412) |
1.9 | 7.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.8 | 5.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.8 | 5.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.8 | 1.8 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
1.8 | 7.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.8 | 24.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.8 | 10.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.7 | 7.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
1.7 | 3.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.7 | 3.5 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
1.7 | 5.2 | GO:0021764 | amygdala development(GO:0021764) |
1.7 | 6.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.7 | 5.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.7 | 3.4 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.7 | 5.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.7 | 6.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.7 | 1.7 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
1.7 | 6.8 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
1.7 | 1.7 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.7 | 1.7 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.7 | 5.1 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.7 | 3.4 | GO:0051795 | positive regulation of catagen(GO:0051795) |
1.7 | 123.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.6 | 4.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.6 | 4.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.6 | 1.6 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
1.6 | 4.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.6 | 6.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
1.6 | 4.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.6 | 4.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.6 | 3.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.6 | 9.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.6 | 8.0 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.6 | 3.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.6 | 1.6 | GO:0021586 | pons maturation(GO:0021586) |
1.6 | 3.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.6 | 4.7 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.6 | 7.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.6 | 4.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.5 | 15.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.5 | 12.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.5 | 3.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.5 | 26.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.5 | 4.6 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.5 | 12.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.5 | 1.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
1.5 | 1.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.5 | 4.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.5 | 5.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.5 | 8.7 | GO:0086009 | membrane repolarization(GO:0086009) |
1.5 | 7.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.4 | 7.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
1.4 | 1.4 | GO:0048382 | mesendoderm development(GO:0048382) |
1.4 | 1.4 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
1.4 | 4.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.4 | 1.4 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.4 | 4.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
1.4 | 2.9 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.4 | 4.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.4 | 4.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.4 | 15.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.4 | 2.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.4 | 4.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.4 | 5.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.4 | 4.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.4 | 5.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.4 | 11.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.4 | 6.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.4 | 9.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.4 | 4.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.4 | 4.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.4 | 5.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.3 | 2.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.3 | 4.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.3 | 4.0 | GO:0030070 | insulin processing(GO:0030070) |
1.3 | 4.0 | GO:0097503 | sialylation(GO:0097503) |
1.3 | 4.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.3 | 1.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.3 | 4.0 | GO:0021885 | forebrain cell migration(GO:0021885) |
1.3 | 2.7 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.3 | 1.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.3 | 5.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.3 | 2.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.3 | 1.3 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
1.3 | 7.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.3 | 1.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.3 | 3.8 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
1.3 | 13.8 | GO:0060074 | synapse maturation(GO:0060074) |
1.3 | 3.8 | GO:0014029 | neural crest formation(GO:0014029) |
1.3 | 21.3 | GO:0010107 | potassium ion import(GO:0010107) |
1.3 | 6.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.2 | 7.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.2 | 3.7 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.2 | 1.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
1.2 | 3.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.2 | 3.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.2 | 4.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.2 | 9.7 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
1.2 | 2.4 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.2 | 4.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.2 | 3.6 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.2 | 3.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.2 | 4.8 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
1.2 | 2.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.2 | 7.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.2 | 1.2 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.2 | 4.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.2 | 2.4 | GO:0015705 | iodide transport(GO:0015705) |
1.2 | 9.4 | GO:0001975 | response to amphetamine(GO:0001975) |
1.2 | 7.1 | GO:0015824 | proline transport(GO:0015824) |
1.2 | 3.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.2 | 4.7 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
1.2 | 9.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.2 | 11.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.2 | 1.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
1.2 | 39.4 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
1.2 | 1.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.2 | 3.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.2 | 3.5 | GO:0014028 | notochord formation(GO:0014028) |
1.2 | 1.2 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
1.2 | 2.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.1 | 3.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
1.1 | 5.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.1 | 3.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.1 | 2.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.1 | 7.9 | GO:0060736 | prostate gland growth(GO:0060736) |
1.1 | 28.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
1.1 | 3.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.1 | 7.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.1 | 2.3 | GO:0051182 | coenzyme transport(GO:0051182) |
1.1 | 1.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.1 | 2.2 | GO:0051665 | membrane raft localization(GO:0051665) |
1.1 | 3.3 | GO:0015747 | urate transport(GO:0015747) |
1.1 | 10.0 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.1 | 2.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
1.1 | 9.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.1 | 2.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.1 | 1.1 | GO:0021794 | thalamus development(GO:0021794) |
1.1 | 17.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.1 | 4.4 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.1 | 2.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.1 | 3.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.1 | 4.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.1 | 2.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.1 | 5.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.1 | 13.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.1 | 12.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.1 | 3.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.1 | 8.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
1.1 | 3.2 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) positive regulation of cardiac muscle contraction(GO:0060452) |
1.0 | 8.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.0 | 6.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.0 | 3.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.0 | 3.1 | GO:0030421 | defecation(GO:0030421) |
1.0 | 1.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
1.0 | 2.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.0 | 16.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.0 | 50.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
1.0 | 1.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.0 | 30.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.0 | 5.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
1.0 | 3.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.0 | 1.0 | GO:0090427 | activation of meiosis(GO:0090427) |
1.0 | 1.0 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.0 | 2.0 | GO:0099612 | protein localization to axon(GO:0099612) |
1.0 | 8.9 | GO:0060384 | innervation(GO:0060384) |
1.0 | 6.9 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
1.0 | 2.0 | GO:0060179 | male mating behavior(GO:0060179) |
1.0 | 2.9 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.0 | 2.9 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.0 | 13.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.0 | 11.6 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.0 | 1.9 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.0 | 2.9 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.0 | 2.9 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.9 | 3.8 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.9 | 2.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.9 | 2.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.9 | 1.9 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.9 | 0.9 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.9 | 2.8 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.9 | 2.7 | GO:0036233 | glycine import(GO:0036233) |
0.9 | 3.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.9 | 3.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.9 | 7.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.9 | 1.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.9 | 2.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.9 | 0.9 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.9 | 1.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.9 | 0.9 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.9 | 2.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.9 | 1.7 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
0.9 | 1.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.8 | 6.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.8 | 1.7 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.8 | 0.8 | GO:0031033 | myosin filament organization(GO:0031033) |
0.8 | 2.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.8 | 1.7 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.8 | 1.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.8 | 1.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.8 | 2.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.8 | 6.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.8 | 2.4 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.8 | 1.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.8 | 0.8 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.8 | 75.8 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.8 | 1.6 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.8 | 2.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.8 | 0.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.8 | 0.8 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.8 | 8.9 | GO:0030238 | male sex determination(GO:0030238) |
0.8 | 0.8 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.8 | 2.4 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.8 | 3.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.8 | 4.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.8 | 0.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.8 | 0.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.8 | 0.8 | GO:0043134 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.8 | 0.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.8 | 1.6 | GO:0042427 | serotonin biosynthetic process(GO:0042427) serotonin metabolic process(GO:0042428) primary amino compound biosynthetic process(GO:1901162) |
0.8 | 6.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.8 | 3.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.8 | 2.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.8 | 5.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.8 | 2.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.8 | 4.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.8 | 1.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.8 | 5.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.8 | 2.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.8 | 1.5 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.8 | 1.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.8 | 1.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.8 | 2.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.8 | 3.0 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 1.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.8 | 0.8 | GO:0060073 | micturition(GO:0060073) |
0.7 | 1.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.7 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.7 | 1.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.7 | 1.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.7 | 3.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.7 | 3.7 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.7 | 1.5 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.7 | 2.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.7 | 1.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.7 | 2.2 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.7 | 2.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.7 | 0.7 | GO:0061548 | ganglion development(GO:0061548) |
0.7 | 1.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.7 | 2.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.7 | 0.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.7 | 0.7 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.7 | 3.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.7 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.7 | 1.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.7 | 2.1 | GO:0030432 | peristalsis(GO:0030432) |
0.7 | 2.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.7 | 2.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.7 | 2.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.7 | 1.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.7 | 2.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.7 | 1.4 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.7 | 8.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.7 | 0.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.7 | 2.1 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.7 | 2.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.7 | 1.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.7 | 0.7 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.7 | 1.4 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.7 | 1.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.7 | 0.7 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.7 | 2.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.7 | 3.3 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.7 | 4.7 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.7 | 2.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.7 | 3.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.7 | 2.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.7 | 1.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 3.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 1.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.6 | 2.6 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.6 | 0.6 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.6 | 3.2 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.6 | 7.0 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.6 | 1.9 | GO:0021756 | striatum development(GO:0021756) |
0.6 | 0.6 | GO:1904238 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.6 | 3.8 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.6 | 3.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 3.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.6 | 3.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.6 | 1.9 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.6 | 2.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 0.6 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.6 | 2.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.6 | 1.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.6 | 3.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.6 | 2.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.6 | 1.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.6 | 1.8 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.6 | 9.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.6 | 3.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.6 | 2.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 3.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 4.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 0.6 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.6 | 6.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.6 | 1.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.6 | 1.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.6 | 0.6 | GO:0086001 | cardiac muscle cell action potential(GO:0086001) |
0.6 | 2.9 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.6 | 2.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.6 | 1.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.6 | 3.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.6 | 1.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.6 | 3.5 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.6 | 1.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.6 | 2.9 | GO:0007512 | adult heart development(GO:0007512) |
0.6 | 2.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.6 | 1.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 1.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.6 | 1.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.6 | 2.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.6 | 0.6 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.6 | 2.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 1.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.5 | 2.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 2.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.5 | 0.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.5 | 1.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.5 | 2.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 6.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.5 | 0.5 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 1.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.5 | 0.5 | GO:0070091 | glucagon secretion(GO:0070091) |
0.5 | 1.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.5 | 14.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.5 | 0.5 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.5 | 2.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.5 | 1.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.5 | 1.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.5 | 1.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 4.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.5 | 1.0 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.5 | 0.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.5 | 2.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.5 | 10.5 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.5 | 2.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.5 | 1.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.5 | 1.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 2.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.5 | 1.0 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.5 | 4.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.5 | 1.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.5 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 5.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.5 | 6.8 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.5 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 1.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.5 | 1.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.5 | 4.7 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.5 | 0.9 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.5 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 1.4 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.5 | 0.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.5 | 0.9 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.5 | 0.9 | GO:0008355 | olfactory learning(GO:0008355) |
0.5 | 1.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 3.2 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.5 | 0.5 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.5 | 2.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.5 | 0.9 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.5 | 0.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.5 | 3.6 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.5 | 0.5 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.5 | 1.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 1.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.5 | 0.5 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.5 | 1.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.5 | 1.8 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.5 | 0.9 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.4 | 1.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 1.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.4 | 4.8 | GO:0002063 | chondrocyte development(GO:0002063) |
0.4 | 7.9 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.4 | 2.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 2.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 2.6 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.4 | 5.7 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 2.2 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.4 | 3.9 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.4 | 2.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 2.6 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.4 | 1.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.4 | 1.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.4 | 3.8 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.4 | 2.5 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 | 1.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.4 | 0.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.4 | 2.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 0.4 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.4 | 4.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.4 | 2.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 1.6 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.4 | 0.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 2.0 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.4 | 1.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.4 | 0.4 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.4 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 2.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.4 | 2.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 0.4 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.4 | 4.3 | GO:0042407 | cristae formation(GO:0042407) |
0.4 | 0.4 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.4 | 1.2 | GO:0042637 | catagen(GO:0042637) |
0.4 | 0.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.4 | 2.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.4 | 3.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.4 | 1.2 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.4 | 1.9 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.4 | 1.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 0.8 | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.4 | 0.4 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.4 | 1.5 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.4 | 3.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.4 | 1.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 1.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.4 | 0.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 1.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.4 | 0.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 0.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 0.7 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.4 | 1.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.4 | 1.8 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.4 | 3.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.4 | 15.5 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.4 | 2.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 1.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.4 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 0.3 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.3 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.3 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) |
0.3 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 1.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.3 | 0.3 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.3 | 1.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.3 | 1.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 1.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.3 | 1.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.7 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.3 | 1.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 1.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.3 | 0.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 1.7 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 1.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.3 | 1.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.7 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.3 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.3 | 0.3 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.3 | 2.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 4.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 0.7 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 1.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 2.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.3 | 2.9 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.3 | 1.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.6 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.3 | 0.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 1.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 1.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 0.6 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 2.2 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 1.6 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.3 | 0.6 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 0.9 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.3 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 0.6 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 1.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 0.3 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 7.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 0.6 | GO:0002434 | immune complex clearance(GO:0002434) |
0.3 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 2.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 0.9 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.3 | 0.6 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.3 | 1.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.3 | 1.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 0.9 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 2.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 2.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 3.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.3 | 0.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 0.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 0.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 0.5 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.3 | 1.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 6.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.3 | 1.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.5 | GO:0050655 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 0.7 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 1.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.7 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 1.7 | GO:0008334 | histone mRNA metabolic process(GO:0008334) histone mRNA catabolic process(GO:0071044) |
0.2 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 1.5 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.2 | 1.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 1.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 1.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 0.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 3.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.2 | 0.9 | GO:0003157 | endocardium development(GO:0003157) |
0.2 | 2.1 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 1.4 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 1.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 1.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 0.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 5.2 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 0.6 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.2 | 1.5 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 2.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 1.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 3.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 11.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 0.4 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.2 | 0.6 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 1.0 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 2.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 1.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.6 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 4.6 | GO:0050808 | synapse organization(GO:0050808) |
0.2 | 0.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.5 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 4.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 0.2 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
0.2 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.2 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.2 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 0.7 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 0.5 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.2 | 0.3 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.2 | GO:0072124 | glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.2 | 0.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 1.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 0.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 1.5 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.2 | 0.8 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.2 | 1.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.4 | GO:0032401 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) establishment of pigment granule localization(GO:0051905) |
0.2 | 0.6 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 0.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.9 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.6 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.6 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 1.0 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.4 | GO:0072044 | collecting duct development(GO:0072044) |
0.1 | 0.4 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.7 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 1.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.4 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.8 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 1.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.3 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 1.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.4 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 1.1 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.1 | 1.6 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.4 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 7.3 | GO:0007409 | axonogenesis(GO:0007409) |
0.1 | 0.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 6.3 | GO:0007626 | locomotory behavior(GO:0007626) |
0.1 | 0.9 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 1.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 2.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.2 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 1.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.5 | GO:0061337 | cardiac conduction(GO:0061337) |
0.1 | 1.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.8 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.3 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.6 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.3 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.1 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.5 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.4 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.1 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:1903659 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.0 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.0 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 1.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.0 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 69.6 | GO:0043194 | axon initial segment(GO:0043194) |
5.3 | 37.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
4.9 | 4.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
4.8 | 14.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
4.8 | 47.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
4.7 | 23.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
4.4 | 22.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
4.4 | 4.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
4.2 | 12.5 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
4.1 | 12.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.6 | 21.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
3.6 | 32.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
3.4 | 6.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
3.2 | 122.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.1 | 85.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.8 | 11.4 | GO:0044308 | axonal spine(GO:0044308) |
2.7 | 16.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
2.6 | 7.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
2.6 | 5.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.6 | 69.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
2.5 | 15.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.5 | 7.4 | GO:0072534 | perineuronal net(GO:0072534) |
2.3 | 6.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.3 | 6.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.1 | 12.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
2.1 | 6.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.1 | 12.6 | GO:0043083 | synaptic cleft(GO:0043083) |
2.1 | 8.4 | GO:1990696 | USH2 complex(GO:1990696) |
2.1 | 10.4 | GO:0097433 | dense body(GO:0097433) |
2.1 | 124.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.0 | 49.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.0 | 32.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.0 | 14.1 | GO:0097449 | astrocyte projection(GO:0097449) |
2.0 | 33.9 | GO:0044295 | axonal growth cone(GO:0044295) |
1.9 | 3.8 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.9 | 7.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.8 | 7.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.8 | 20.2 | GO:0032433 | filopodium tip(GO:0032433) |
1.8 | 5.5 | GO:0097441 | basilar dendrite(GO:0097441) |
1.7 | 5.2 | GO:1990393 | 3M complex(GO:1990393) |
1.7 | 19.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.7 | 59.7 | GO:0043198 | dendritic shaft(GO:0043198) |
1.7 | 5.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.6 | 9.8 | GO:0032584 | growth cone membrane(GO:0032584) |
1.6 | 9.8 | GO:0030673 | axolemma(GO:0030673) |
1.6 | 16.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.6 | 1.6 | GO:0044299 | C-fiber(GO:0044299) |
1.5 | 4.6 | GO:0097427 | microtubule bundle(GO:0097427) |
1.5 | 13.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.5 | 4.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.5 | 226.9 | GO:0060076 | excitatory synapse(GO:0060076) |
1.5 | 14.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.4 | 1.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.3 | 1.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.3 | 4.0 | GO:0033269 | internode region of axon(GO:0033269) |
1.3 | 128.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.3 | 11.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.3 | 1.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.2 | 15.4 | GO:0034704 | calcium channel complex(GO:0034704) |
1.2 | 1.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.2 | 3.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.1 | 3.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.1 | 3.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.1 | 87.5 | GO:0030427 | site of polarized growth(GO:0030427) |
1.0 | 3.1 | GO:0033010 | paranodal junction(GO:0033010) |
1.0 | 3.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 9.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.0 | 3.0 | GO:0043511 | inhibin complex(GO:0043511) |
1.0 | 3.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 2.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.9 | 11.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.9 | 3.7 | GO:0000235 | astral microtubule(GO:0000235) |
0.9 | 5.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.9 | 1.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.9 | 2.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.9 | 4.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 11.8 | GO:0044298 | cell body membrane(GO:0044298) |
0.8 | 9.3 | GO:0042555 | MCM complex(GO:0042555) |
0.8 | 7.5 | GO:0060091 | kinocilium(GO:0060091) |
0.8 | 1.6 | GO:0031045 | dense core granule(GO:0031045) |
0.8 | 2.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 4.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.8 | 3.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.8 | 12.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 40.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.7 | 41.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 3.3 | GO:0071547 | piP-body(GO:0071547) |
0.7 | 168.8 | GO:0045202 | synapse(GO:0045202) |
0.6 | 3.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 5.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 1.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.6 | 1.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.6 | 2.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 2.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 1.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.6 | 1.7 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 4.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 4.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.5 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 4.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.5 | 2.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 2.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.5 | 1.5 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 7.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 4.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.5 | 5.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 5.3 | GO:0001527 | microfibril(GO:0001527) |
0.5 | 12.0 | GO:0030175 | filopodium(GO:0030175) |
0.5 | 1.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 3.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.5 | 1.8 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 1.8 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 1.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 1.7 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 3.8 | GO:0005687 | U4 snRNP(GO:0005687) |
0.4 | 2.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 3.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 2.0 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 1.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 3.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.4 | 2.6 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.4 | 2.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 3.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 0.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.3 | 1.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 2.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.3 | 3.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 1.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 2.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 3.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 0.6 | GO:0097386 | glial cell projection(GO:0097386) |
0.3 | 3.2 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 2.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.3 | 33.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 7.0 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.7 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 2.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 5.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 1.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 0.7 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.2 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 3.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 19.2 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 1.1 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.7 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 1.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 1.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 3.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 2.4 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.5 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.1 | GO:0071438 | invadopodium(GO:0071437) invadopodium membrane(GO:0071438) |
0.1 | 0.5 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.4 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.6 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 3.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 3.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 1.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.8 | 29.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
7.2 | 21.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
6.8 | 34.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
6.5 | 19.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
6.2 | 12.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
5.3 | 21.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
5.3 | 21.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
5.1 | 10.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
5.0 | 15.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
5.0 | 25.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
4.7 | 14.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
4.5 | 13.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
4.5 | 22.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.3 | 17.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
4.2 | 4.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
4.1 | 12.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
4.1 | 12.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
4.0 | 12.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
4.0 | 31.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
3.8 | 11.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
3.6 | 14.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
3.5 | 21.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
3.5 | 10.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.5 | 7.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
3.5 | 27.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
3.3 | 9.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
3.3 | 3.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
3.2 | 9.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.0 | 12.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.9 | 14.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.8 | 30.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
2.7 | 10.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.7 | 21.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.7 | 13.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.5 | 12.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.5 | 12.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.5 | 75.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
2.5 | 9.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.4 | 53.6 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
2.4 | 31.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
2.4 | 9.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.4 | 9.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.4 | 7.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
2.4 | 4.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
2.3 | 4.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.3 | 43.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
2.2 | 11.1 | GO:0048495 | Roundabout binding(GO:0048495) |
2.2 | 8.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.2 | 6.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.2 | 6.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.1 | 31.9 | GO:0031402 | sodium ion binding(GO:0031402) |
2.0 | 6.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
2.0 | 4.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.0 | 24.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
2.0 | 8.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
2.0 | 6.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.9 | 5.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.9 | 3.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.9 | 7.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.9 | 7.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.9 | 11.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.7 | 8.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.7 | 19.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.7 | 5.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.7 | 34.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.7 | 55.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.7 | 17.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.7 | 39.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.7 | 6.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.6 | 6.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.6 | 8.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.5 | 6.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.5 | 12.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.5 | 4.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.5 | 6.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.5 | 5.9 | GO:0097001 | ceramide binding(GO:0097001) |
1.5 | 5.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.5 | 10.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.5 | 2.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.5 | 16.0 | GO:0005522 | profilin binding(GO:0005522) |
1.4 | 17.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.4 | 4.2 | GO:0051373 | FATZ binding(GO:0051373) |
1.4 | 40.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.4 | 5.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.4 | 4.1 | GO:0005267 | potassium channel activity(GO:0005267) |
1.4 | 12.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.4 | 12.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.4 | 6.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.4 | 17.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.3 | 5.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.3 | 2.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.3 | 3.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.3 | 3.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.3 | 3.9 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.3 | 1.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.3 | 3.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.3 | 3.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.3 | 29.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.3 | 7.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.3 | 8.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.3 | 11.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.3 | 3.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.2 | 3.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.2 | 12.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.2 | 17.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
1.2 | 2.4 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.2 | 3.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.2 | 5.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.2 | 4.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.1 | 1.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.1 | 17.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 5.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.1 | 4.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.1 | 5.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.1 | 6.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.1 | 2.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.0 | 3.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.0 | 28.1 | GO:0030507 | spectrin binding(GO:0030507) |
1.0 | 25.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.0 | 1.0 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
1.0 | 5.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.0 | 3.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.0 | 3.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.0 | 8.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.0 | 19.6 | GO:0003785 | actin monomer binding(GO:0003785) |
1.0 | 2.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.0 | 3.8 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.0 | 4.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.0 | 3.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.9 | 22.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.9 | 2.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.9 | 2.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.9 | 9.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.9 | 5.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.9 | 1.8 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.9 | 8.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.9 | 5.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.9 | 11.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.9 | 2.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.9 | 2.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.9 | 8.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 2.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.9 | 4.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 1.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.9 | 1.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.8 | 2.5 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.8 | 10.1 | GO:0031005 | filamin binding(GO:0031005) |
0.8 | 8.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.8 | 16.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 9.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.8 | 4.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.8 | 12.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.8 | 11.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.8 | 2.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 0.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.8 | 5.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.7 | 21.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.7 | 8.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 2.9 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.7 | 12.3 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 12.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.7 | 5.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.7 | 9.1 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.7 | 4.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 4.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.7 | 2.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 4.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.7 | 4.8 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.7 | 2.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 25.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.7 | 5.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.7 | 1.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.7 | 10.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.7 | 3.3 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.7 | 11.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.6 | 3.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 3.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.6 | 1.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.6 | 1.9 | GO:0034903 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.6 | 17.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.6 | 2.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 1.9 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 2.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 1.8 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.6 | 3.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 3.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.6 | 1.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 0.6 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.6 | 4.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.6 | 2.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 3.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.6 | 1.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.6 | 1.8 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.6 | 7.1 | GO:0005272 | sodium channel activity(GO:0005272) |
0.6 | 1.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.6 | 7.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.6 | 2.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.6 | 6.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.6 | 6.7 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.6 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 1.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.6 | 6.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 2.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.6 | 1.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.5 | 2.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 2.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.5 | 4.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 2.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 2.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 1.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 3.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 0.5 | GO:0051870 | methotrexate binding(GO:0051870) |
0.5 | 1.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 2.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 1.5 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.5 | 1.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 1.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 1.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.5 | 1.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.5 | 3.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 3.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.5 | 0.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 1.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.4 | 1.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 1.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 8.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 2.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 1.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.4 | 1.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 2.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 2.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 1.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 8.1 | GO:0005537 | mannose binding(GO:0005537) |
0.4 | 1.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 1.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 1.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.4 | 2.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 11.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 4.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.4 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 6.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.4 | 1.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.4 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 0.4 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.4 | 7.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 2.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 1.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 1.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 1.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 0.3 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 2.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 1.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 1.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 12.7 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 3.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 6.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 3.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 1.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 5.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 1.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 6.8 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.3 | 1.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 2.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 4.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 5.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 5.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 0.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 0.9 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 2.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 1.8 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 2.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 2.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 1.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 5.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 0.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 14.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 1.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 2.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 2.4 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.3 | 0.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 2.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 9.9 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.3 | 2.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 1.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 19.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 0.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 4.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 1.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 1.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 11.9 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 1.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.1 | GO:0005165 | neurotrophin receptor binding(GO:0005165) neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 2.4 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.2 | 1.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 1.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 11.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 2.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.8 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 4.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 2.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 22.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 2.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 2.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 0.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 1.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 3.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.4 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 3.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 14.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 2.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.6 | GO:0043762 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 5.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.2 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 2.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.2 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.0 | 19.5 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 1.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 5.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0032183 | SUMO binding(GO:0032183) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 3.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
2.7 | 87.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.8 | 23.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.7 | 1.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.4 | 1.4 | PID IGF1 PATHWAY | IGF1 pathway |
1.4 | 20.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.3 | 1.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.1 | 37.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.1 | 24.2 | PID REELIN PATHWAY | Reelin signaling pathway |
1.0 | 1.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.9 | 8.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.9 | 30.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.8 | 3.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.8 | 8.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.7 | 9.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.7 | 15.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.7 | 5.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.6 | 14.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 10.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.5 | 12.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 8.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 4.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 4.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 17.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.4 | 7.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 5.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 3.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 4.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 2.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 4.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 5.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 5.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 3.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 3.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 2.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 1.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 4.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 3.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 10.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 61.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.5 | 52.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
3.5 | 41.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.7 | 2.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
2.7 | 56.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.7 | 10.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.6 | 43.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.5 | 101.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
2.2 | 24.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.2 | 17.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.2 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
2.1 | 47.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.0 | 2.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.9 | 23.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.9 | 26.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.9 | 1.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
1.8 | 42.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.8 | 5.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.6 | 34.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.5 | 4.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.5 | 33.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.4 | 56.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.4 | 27.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.4 | 2.9 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.2 | 4.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.2 | 13.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.1 | 7.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.1 | 8.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.1 | 24.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.0 | 2.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
1.0 | 9.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.0 | 24.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.0 | 13.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.9 | 10.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.9 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.9 | 13.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 11.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.8 | 8.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 1.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.8 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.8 | 10.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.8 | 2.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.8 | 5.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.7 | 9.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.7 | 10.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.7 | 8.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.7 | 7.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.7 | 24.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.6 | 2.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 4.9 | REACTOME OPSINS | Genes involved in Opsins |
0.6 | 6.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.6 | 11.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.6 | 2.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.6 | 10.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.6 | 4.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.6 | 9.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 15.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.5 | 11.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.5 | 6.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.5 | 2.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 10.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.5 | 5.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 1.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.5 | 4.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 4.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 2.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 2.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 1.0 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.3 | 3.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 1.2 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.3 | 6.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.3 | 3.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 2.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 1.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 1.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 3.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 0.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 2.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 3.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 2.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 3.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 1.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 1.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 10.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 0.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 3.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 2.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 3.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 3.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.7 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 2.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 3.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 3.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.4 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |